Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04424979
Other study ID # MPP_Feasibility1
Secondary ID R01EY023385
Status Recruiting
Phase N/A
First received
Last updated
Start date November 6, 2020
Est. completion date August 2024

Study information

Verified date March 2024
Source Massachusetts Eye and Ear Infirmary
Contact Sailaja Manda
Phone 617 912 2522
Email sailaja_manda@meei.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will develop and test different configurations of high-power prisms to expand the field of vision of patients with visual field loss to assist them with obstacle detection when walking. The study will involve multiple visits (typically four) to Schepens Eye Research Institute for fitting and testing with the prism glasses. The overall objective is to determine best designs and fitting parameters for implementation in prism devices for future clinical trials.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 7 Years to 80 Years
Eligibility Inclusion Criteria: - Visual field loss, either peripheral field loss or hemianopic field loss - Visual acuity of at least 20/50 in the better eye - In sufficiently good health to be able to complete sessions lasting 2-4 hours - Able to independently walk short distances - Able to give voluntary, informed consent - Able to speak English Exclusion Criteria: - Any physical or mental impairments, including cognitive dysfunction, balance problems or other deficits that could impair the ability to walk or use the prism spectacles - A history of seizures in the last 6 months - Hemispatial neglect (subjects with hemianopic field loss only)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
High power prisms
High power prisms designed to shift images from blind areas into portions of the wearer's remaining, seeing, field of vision

Locations

Country Name City State
United States Schepens Eye Research Institute Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts Eye and Ear Infirmary National Eye Institute (NEI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Field of view expansion Horizontal and vertical extent of the expansion (in degrees) of the field of view Through study completion, an average of four months
Secondary Pedestrian detection rate Proportion of pedestrians detected (in simulated walking or simulated driving) Through study completion, an average of four months
See also
  Status Clinical Trial Phase
Completed NCT05169983 - Feasibility of Visual Field Screening Apps
Completed NCT04786886 - Patient Performance and Acceptance of Virtual Reality Visual Field Devices N/A
Recruiting NCT06047717 - Vision Loss Impact on Navigation in Virtual Reality N/A
Recruiting NCT05141604 - Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking N/A
Completed NCT04175444 - Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer
Recruiting NCT04798924 - Visual Rehabilitation After Occipital Stroke N/A
Recruiting NCT06241209 - Hemianopsia Rehabilitation After Stroke or Brain Injury N/A
Recruiting NCT05085210 - Improving Visual Field Deficits With Noninvasive Brain Stimulation N/A
Recruiting NCT05150197 - Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease N/A
Completed NCT03797469 - Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) N/A